Analyzing Oscar Health (OSCR) & Its Peers

Oscar Health (NYSE:OSCR) is one of 233 publicly-traded companies in the “Healthcare Providers & Services” industry, but how does it weigh in compared to its rivals? We will compare Oscar Health to similar companies based on the strength of its analyst recommendations, dividends, valuation, risk, earnings, profitability and institutional ownership.

Profitability

This table compares Oscar Health and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Oscar Health	3.60%	38.45%	6.76%
Oscar Health Competitors	-8.01%	-140.31%	-1.38%

Valuation & Earnings

This table compares Oscar Health and its rivals top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Oscar Health	$15.32 billion	-$443.15 million	21.96
Oscar Health Competitors	$19.20 billion	$288.54 million	12.92

Oscar Health’s rivals have higher revenue and earnings than Oscar Health. Oscar Health is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Insider & Institutional Ownership

75.7% of Oscar Health shares are owned by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 22.6% of Oscar Health shares are owned by company insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Oscar Health and its rivals, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oscar Health	1	7	4	1	2.38
Oscar Health Competitors	1859	7716	13322	815	2.55

Oscar Health presently has a consensus price target of $34.60, indicating a potential upside of 12.55%. As a group, “Healthcare Providers & Services” companies have a potential upside of 14.55%. Given Oscar Health’s rivals stronger consensus rating and higher probable upside, analysts clearly believe Oscar Health has less favorable growth aspects than its rivals.

Risk & Volatility

Oscar Health has a beta of 2.56, indicating that its share price is 156% more volatile than the S&P 500. Comparatively, Oscar Health’s rivals have a beta of 0.99, indicating that their average share price is 1% less volatile than the S&P 500.

Summary

Oscar Health beats its rivals on 8 of the 13 factors compared.

Oscar Health Company Profile

Oscar Health, Inc. operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.